share_log

SciSparc | SC 13G: Statement of acquisition of beneficial ownership by individuals-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%), etc.

サイスパーク | SC 13G:大量保有報告書-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%)など

SEC announcement ·  03/06 17:07
Moomoo AIのまとめ
On February 27, 2024, a Schedule 13G was filed with the U.S. Securities and Exchange Commission by several entities, indicating a collective beneficial ownership of 115,482 ordinary shares of SciSparc Ltd., which represents 9.99% of the company's class of securities. The reporting entities include YA II PN, Ltd., YA Global Investments II (U.S.), LP, Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YA II GP, LP, YAII GP II, LLC, Mark Angelo, and SC-Sigma Global Partners, LP. These shares consist of direct ownership and the right to acquire additional shares under a Standby Equity Purchase Agreement (SEPA) with SciSparc Ltd. The entities have agreed to file this statement jointly, and each entity disclaims beneficial ownership of the securities owned by the others. The filing indicates that the shares were not acquired for the purpose of changing or influencing the control of SciSparc Ltd.
On February 27, 2024, a Schedule 13G was filed with the U.S. Securities and Exchange Commission by several entities, indicating a collective beneficial ownership of 115,482 ordinary shares of SciSparc Ltd., which represents 9.99% of the company's class of securities. The reporting entities include YA II PN, Ltd., YA Global Investments II (U.S.), LP, Yorkville Advisors Global, LP, Yorkville Advisors Global II, LLC, YA II GP, LP, YAII GP II, LLC, Mark Angelo, and SC-Sigma Global Partners, LP. These shares consist of direct ownership and the right to acquire additional shares under a Standby Equity Purchase Agreement (SEPA) with SciSparc Ltd. The entities have agreed to file this statement jointly, and each entity disclaims beneficial ownership of the securities owned by the others. The filing indicates that the shares were not acquired for the purpose of changing or influencing the control of SciSparc Ltd.
2024年2月27日、複数の団体によって米国証券取引委員会に対してスケジュール13Gが提出され、SciSparc Ltd.の普通株式11万5,482株の集合的な有益所有権が示されました。これは同社の証券クラスの9.99%に相当します。報告団体には、YA II PN、Ltd.、YA Global Investments II(U.S.)、LP、Yorkville Advisors Global、LP、Yorkville Advisors Global II、LLC、YA II GP、LP、YAII GP II、LLC、Mark Angelo、およびSC-Sigma Global Partners...すべて展開
2024年2月27日、複数の団体によって米国証券取引委員会に対してスケジュール13Gが提出され、SciSparc Ltd.の普通株式11万5,482株の集合的な有益所有権が示されました。これは同社の証券クラスの9.99%に相当します。報告団体には、YA II PN、Ltd.、YA Global Investments II(U.S.)、LP、Yorkville Advisors Global、LP、Yorkville Advisors Global II、LLC、YA II GP、LP、YAII GP II、LLC、Mark Angelo、およびSC-Sigma Global Partners、LPが含まれます。これらの株式は、SciSparc Ltd.とのスタンバイ株式購入契約書(SEPA)に基づく直接所有および追加株式の取得権を含んでいます。団体は共同でこの声明を提出することに合意しており、各団体は他の者が所有する証券の有益所有権を否認しています。この報告書は、株式を取得する目的がSciSparc Ltd.の支配権の変更や影響を与えることではないことを示しています。
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報